Coinsilium Group #COIN – Raises £247,500 in Warrant Exercises March 2, 2021 – Posted in: Blog, Coinsilium (COIN)

2nd March, 2021 COINSILIUM GROUP LIMITED (“Coinsilium” or the “Company”) Coinsilium Group Limited: Exercise of Warrants Coinsilium Group Limited (AQSE:COIN) (OTCQB:CINGF) the Blockchain and Open Finance venture builder, is pleased to announce that it has received notice from IOV Labs Limited (IOV) of the early exercise of warrants over 5,500,00 new ordinary shares in the Company at a price of 4.5p for a total consideration of GBP247,500. IOV Labs, Coinsilium’s largest shareholder, is a Gibraltar registered company…

Continue reading

Tiziana Life Sciences – Issue of Equity on Exercise of Warrants October 20, 2020 – Posted in: Tiziana Life Sciences (TILS)

20th October, 2020 Tiziana Life Sciences Plc (“Tiziana” or the “Company”) Issue of Equity on Exercise of Warrants Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and issued 35,714 ordinary shares of 3 pence each (“New Ordinary Shares”) credited as fully paid at a price of 70 pence per share in…

Continue reading

Tiziana Life Sciences – Exercise of Warrants & Issue of Equity & Total Voting Rights July 24, 2020 – Posted in: Uncategorized

  24th July, 2020 Tiziana Life Sciences plc (“Tiziana” or the “Company”)    Exercise of Warrants and Issue of Equity and Total Voting Rights London, New York, 24 July 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and issued 88,580 ordinary shares of 3 pence each (“New Ordinary Shares”) credited as fully paid in respect of…

Continue reading

Open Orphan – Exercise of Investor Warrants by Investors and Issue of Shares July 7, 2020 – Posted in: Open Orphan (ORPH)

7 July 2020   Open Orphan plc (“Open Orphan” or the “Company”) Exercise of Investor Warrants by Investors and Issue of Shares Open Orphan plc (ORPH), the rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge study models, has received notices of exercise of warrants by investors who participated in the Venn loan note financing in December 2018 over 1,749,732 ordinary shares of  0.1 pence each…

Continue reading

Tiziana Life Sciences plc – Exercise of Warrants and Issue of Equity and Total Voting Rights June 22, 2020 – Posted in: Tiziana Life Sciences (TILS)

Monday 22nd June, 2020 Tiziana Life Sciences plc (“Tiziana” or the “Company”)  Exercise of Warrants and Issue of Equity and Total Voting Rights London, New York, 22 June 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the “Company” or “Tiziana”), a US and UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, today announces that it has allotted and issued 1,800,000 ordinary shares of 3 pence each (“New Ordinary Shares”)…

Continue reading

Tiziana Life Sciences Plc – Exercise of Warrants and Issue of Equity and Total Voting Rights June 3, 2020 – Posted in: Tiziana Life Sciences (TILS)

Tiziana Life Sciences plc (“Tiziana” or the “Company”) Correction – Exercise of Warrants and Issue of Equity and Total Voting Rights The announcement (RNS Number: 6069O) released on 2 June 2020 at 07:00 am stated that 1,498,685 new ordinary shares will be issued yielding £710,843 in cash proceeds, the announcement should have stated the number of shares to be issued is 1,234,399, yielding £578,700 cash proceeds. All other details in the announcement remain unchanged. The amended announcement is set out below:…

Continue reading

Open Orphan (ORPH) Exercise of Warrants and Issue of Shares September 23, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, announces that the Company has received notices of exercise of warrants over 539,654 ordinary shares of 0.1 pence each in the capital of the Company (“Ordinary Shares”) at a price of 0.1 pence per share for 191,051 ordinary shares and at a price of 2.2 pence per share for 348,603 ordinary shares. The gross proceeds of this exercise received by the Company amounts to…

Continue reading